Arcus Biosciences, Inc.
TETRALIN AND TETRAHYDROQUINOLINE COMPOUNDS AS INHIBITORS OF HIF-2ALPHA
Last updated:
Abstract:
Compounds that inhibit HIF-2.alpha., and compositions containing the compound(s) and methods for synthesizing the compounds, are described herein. Also described are the use of such compounds and compositions for the treatment of a diverse array of diseases, disorders, and conditions, including cancer- and immune-related disorders that are mediated, at least in part, by HIF-2.alpha..
Status:
Application
Type:
Utility
Filling date:
18 Mar 2021
Issue date:
14 Oct 2021